- Home
- ISRL vs BTMD Comparison
ISRL vs BTMD Comparison
Compare ISRL & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISRL | BTMD |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.3M | 90.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ISRL | BTMD |
|---|---|---|
| Price | $12.50 | $2.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 1.3K | ★ 141.0K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | 0.04 | ★ 0.78 |
| Revenue | N/A | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | $231.49 | ★ $3.29 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $11.22 | $2.32 |
| 52 Week High | $14.00 | $6.98 |
Technical Indicators
Market Signals| Indicator | ISRL | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.09 | 42.73 |
| Support Level | $12.34 | $2.32 |
| Resistance Level | $12.38 | $2.75 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 100.00 | 40.86 |
Price Performance
Historical ComparisonAbout ISRL Israel Acquisitions Corp
Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.